Bruna Amanda da Cruz Rattis

Dr. Bruna Amanda da Cruz Rattis


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BRBruna Amanda da Cruz Rattis
Bruna Amanda da Cruz Rattis
HPHenrique L. Piva
Henrique L. Piva
ADAndressa Duarte
Andressa Duarte
FGFrederico G. F. L. R. Gomes
Frederico G. F. L. R. Gomes
JLJanaína R. Lellis
Janaína R. Lellis
Mara Rubia Nunes CelesMara Rubia Nunes Celes
Mara Rubia Nunes Celes
MTOR is a signaling pathway involved in cell survival, cell stress response, and protein synthesis that may be a key point in sepsis-induced cardiac dysfunction. Curcumin has been reported in vitro as an mTOR inhibitor compound; however, there are no studies demonstrating this effect in experimental sepsis. Thus, this study aimed to evaluate the action of curcumin on the mTOR pathway in the heart of septic mice. Free curcumin (FC) and nanocurcumin (NC) were used, and samples were obtained at 24 and 120 h after sepsis. Histopathological and ultrastructural analysis showed that treatments with FC and NC reduced cardiac lesions caused by sepsis. Our main results demonstrated that curcumin reduced mTORC1 and Raptor mRNA at 24 and 120 h compared with the septic group; in contrast, mTORC2 mRNA increased at 24 h. Additionally, the total mTOR mRNA expression was reduced at 24 h compared with the septic group. Our results indicate that treatment with curcumin and nanocurcumin promoted a cardioprotective response that could be related to the modulation of the mTOR pathway.
1

16 August 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
SRSimone G. Ramos
Simone G. Ramos
Giulia OttavianiGiulia Ottaviani
Giulia Ottaviani
LPLuiz Cesar Peres
Luiz Cesar Peres
BRBruna Amanda da Cruz Rattis
Bruna Amanda da Cruz Rattis
PLPatricia dos Santos Leão
Patricia dos Santos Leão
EDEliane Pedra Dias
Eliane Pedra Dias
At some point in history, medicine was integrated with pathology, more precisely, with pathological anatomy

4 December 2021 in Viruses
Verified
Journal Article
Open access
PDF file
MFMarcilio Fumagalli
Marcilio Fumagalli
LCLuiza Antunes Castro-Jorge
Luiza Antunes Castro-Jorge
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
PAPatrick Orestes de Azevedo
Patrick Orestes de Azevedo
CCCarlos Fabiano Capato
Carlos Fabiano Capato
LFLuiz Tadeu Figueiredo
Luiz Tadeu Figueiredo
The persistent circulation of SARS-CoV-2 represents an ongoing global threat due to the emergence of new viral variants that can sometimes evade the immune system of previously exposed or vaccinated individuals. We conducted a follow-up study of adult individuals that had received an inactivated SARS-CoV-2 vaccine, evaluating antibody production and neutralizing activity over a period of 6 months. In addition, we performed mice immunization with inactivated SARS-CoV-2, and evaluated the immune response and pathological outcomes against Gamma and Zeta variant infection. Vaccinated individuals produced high levels of antibodies with robust neutralizing activity, which was significantly reduced against Gamma and Zeta variants. Production of IgG anti-S antibodies and neutralizing activity robustly reduced after 6 months of vaccination. Immunized mice demonstrated cellular response against Gamma and Zeta variants, and after viral infection, reduced viral loads, IL-6 expression, and histopathological outcome in the lungs. TNF levels were unchanged in immunized or not immunized mice after infection with the Gamma variant. Furthermore, serum neutralization activity rapidly increases after infection with the Gamma and Zeta variants. Our data suggest that immunization with inactivated WT SARS-CoV-2 induces a promptly responsive cross-reactive immunity response against the Gamma and Zeta variants, reducing COVID-19 pathological outcomes.

18 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
PRPatricia Brito Rodrigues
Patricia Brito Rodrigues
GGGiovanni Freitas Gomes
Giovanni Freitas Gomes
MAMonara Angelim
Monara Angelim
GSGabriela De Souza
Gabriela De Souza
SMStefanie Muraro
Stefanie Muraro
MVMarco Aurélio Vinolo
Marco Aurélio Vinolo
Clinical and experimental data indicate that severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection is associated with significant changes in the composition and function of intestinal microbiota. However, the relevance of these effects for SARS-CoV-2 pathophysiology is unknown. In this study, we analyzed the impact of microbiota depletion after antibiotic treatment on the clinical and immunological responses of K18-hACE2 mice to SARS-CoV-2 infection. Mice were treated with a combination of antibiotics (kanamycin, gentamicin, metronidazole, vancomycin, and colistin, Abx) for 3 days, and 24 h later, they were infected with SARS-CoV-2 B lineage. Here, we show that more than 80% of mice succumbed to infection by day 11 post-infection. Treatment with Abx had no impact on mortality. However, Abx-treated mice presented better clinical symptoms, with similar weight loss between infected–treated and non-treated groups. We observed no differences in lung and colon histopathological scores or lung, colon, heart, brain and kidney viral load between groups on day 5 of infection. Despite some minor differences in the expression of antiviral and inflammatory markers in the lungs and colon, no robust change was observed in Abx-treated mice. Together, these findings indicate that microbiota depletion has no impact on SARS-CoV-2 infection in mice.

23 June 2026 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
RSRafaela Lúcia Lopes de Souza
Rafaela Lúcia Lopes de Souza
LBLuciana Benevides
Luciana Benevides
TRThaís da Silva Rigoni
Thaís da Silva Rigoni
RARodrigo Paolo Flores Abuna
Rodrigo Paolo Flores Abuna
BRBruna Amanda da Cruz Rattis
Bruna Amanda da Cruz Rattis
JSJoão Santana da Silva
João Santana da Silva
Here, we aim to determine the effect of previous infection with Paracoccidioides brasiliensis (Pb18), a primary human pathogenic fungus, associated with high mortality and morbidity rates, on the outcome of SARS-CoV-2 infection. The K18hACE2 transgenic mice were infected with 1 × 106 yeasts of the Pb18 fungus followed by the infection with 5 × 104 Plaque-Forming Unit (PFU) of the SARS-CoV-2 virus. The coinfected mice exhibit lower weight loss and mortality compared to mice infected with the virus alone. Moreover, the inflammatory infiltrate and the viral load of lung, heart, spleen, and brain were lower, suggesting that prior infection with the Pb18 leads to increased resistance against the virus infection. In addition, after SARS-CoV-2 infection, a lower frequency of inflammatory monocytes in the lung tissue of mice previously infected with Pb18 was found. We also observed that mice infected only with SARS-CoV-2 had higher expression of pro-inflammatory cytokines and lower frequency of dendritic cells, alveolar and interstitial macrophages and T lymphocytes in lung tissue compared to mice coinfected or infected only with the fungus. The fungus-induced resistance is dependent on the IFN-I signaling pathway, since treatment with antibody against IFNAR impaired animal survival and viral load. This study reveals a distinct outcome compared to what is typically observed in opportunistic fungal coinfections, highlighting the pathways necessary to induce resistance against viral infections.